ICER to Assess Roxadustat for Treatment Anemia in Chronic Kidney Disease
Sydney Otomancek2023-12-14T13:18:00-05:00June 26th, 2020|Categories: Featured, Industry News|Tags: Anemia, Chronic Kidney Disease, Healtheconomics.com, HEOR, ICER, Institute for Clinical and Economic Review, market access|
The Institute for Clinical and Economic Review (ICER) announced plans to assess FibroGen's roxadustat for the treatment of anemia in [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
Thursday, May 23, 2024
Sponsor: OM1
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Wednesday, May 1, 2024
Webinar Host: Scientist.com
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
HEOR
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Press Release
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication